Stellar Biotechnologies Stock Price, News & Analysis (NASDAQ:SBOT) Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Stellar Biotechnologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Today's Range N/A50-Day Range$4.44MA: $59,624.23▼$298,098.0052-Week Range N/AVolume625,292 shsAverage Volume2.95 million shsMarket Capitalization$1,588.86 billionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Stellar Biotechnologies, Inc, a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin (KLH) protein in Europe, North America, and Asia. The company offers KLH, an immune-stimulating protein used in the production of various immunotherapies; and as a carrier molecule or finished injectable product in the immunodiagnostic market. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SBOT Previous Symbol CUSIPN/A CIK1540159 Webhttp://www.stellarbiotechnologies.com/ Phone805-488-2800Debt Debt-to-Equity RatioN/A Current Ratio9.24 Quick Ratio8.96Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$210,000.00 Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$2.12 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)($1.76) Net Income$-5,030,000.00 Net Margins-1,782.64% Return on Equity-51.12% Return on Assets-48.37%Miscellaneous Employees25 Outstanding Shares5,330,000Market Cap$1,588.86 billion Next Earnings Date11/29/2019 (Estimated) OptionableNot Optionable NASDAQ:SBOT Rates by TradingView Receive SBOT News and Ratings via Email Sign-up to receive the latest news and ratings for SBOT and its competitors with MarketBeat's FREE daily newsletter. Stellar Biotechnologies (NASDAQ:SBOT) Frequently Asked Questions What is Stellar Biotechnologies' stock symbol? Stellar Biotechnologies trades on the NASDAQ under the ticker symbol "SBOT." When did Stellar Biotechnologies' stock split? How did Stellar Biotechnologies' stock split work? Stellar Biotechnologies's stock reverse split on the morning of Monday, May 7th 2018. The 1-7 reverse split was announced on Friday, April 27th 2018. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 4th 2018. An investor that had 100 shares of Stellar Biotechnologies stock prior to the reverse split would have 14 shares after the split. How were Stellar Biotechnologies' earnings last quarter? Stellar Biotechnologies Inc (NASDAQ:SBOT) released its earnings results on Wednesday, May, 8th. The biotechnology company reported ($0.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by $0.05. The biotechnology company earned $0.12 million during the quarter, compared to analyst estimates of $0.11 million. Stellar Biotechnologies had a negative return on equity of 51.12% and a negative net margin of 1,782.64%. View Stellar Biotechnologies' Earnings History. When is Stellar Biotechnologies' next earnings date? Stellar Biotechnologies is scheduled to release their next quarterly earnings announcement on Friday, November 29th 2019. View Earnings Estimates for Stellar Biotechnologies. Has Stellar Biotechnologies been receiving favorable news coverage? Headlines about SBOT stock have been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Stellar Biotechnologies earned a media sentiment score of -1.3 on InfoTrie's scale. They also assigned media stories about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Stellar Biotechnologies. Who are some of Stellar Biotechnologies' key competitors? Some companies that are related to Stellar Biotechnologies include Johnson & Johnson (JNJ), Roche Holdings AG Basel (RHHBY), Merck & Co., Inc. (MRK), Pfizer (PFE), Novartis (NVS), Abbott Laboratories (ABT), Novo Nordisk A/S (NVO), Sanofi (SNY), AstraZeneca (AZN), Eli Lilly And Co (LLY), AbbVie (ABBV), GlaxoSmithKline (GSK), Bristol-Myers Squibb (BMY), Commonwealth Bank of Australia (CSLLY) and Celgene (CELG). What other stocks do shareholders of Stellar Biotechnologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Stellar Biotechnologies investors own include Nexgen Energy (NXE), Progenics Pharmaceuticals (PGNX), Anavex Life Sciences (AVXL), Eyepoint Pharmaceuticals (EYPT), Opko Health (OPK), Rigel Pharmaceuticals (RIGL), Verastem (VSTM), XOMA (XOMA), Statoil (STO) and TransEnterix (TRXC). Who are Stellar Biotechnologies' key executives? Stellar Biotechnologies' management team includes the folowing people: Mr. Frank R. Oakes, Chairman, Pres & CEO (Age 69)Ms. Kathi Niffenegger CPA, CFO & Corp. Sec. (Age 62)Mr. Gary Koppenjan, Sr. Director of Investor Relations & CommunicationsBrando Lincicum, Exec. Director of Aquaculture and Facility Operations How big of a company is Stellar Biotechnologies? Stellar Biotechnologies has a market capitalization of $0.00 and generates $210,000.00 in revenue each year. The biotechnology company earns $-5,030,000.00 in net income (profit) each year or ($1.76) on an earnings per share basis. Stellar Biotechnologies employs 25 workers across the globe.View Additional Information About Stellar Biotechnologies. What is Stellar Biotechnologies' official website? The official website for Stellar Biotechnologies is http://www.stellarbiotechnologies.com/. How can I contact Stellar Biotechnologies? Stellar Biotechnologies' mailing address is 332 EAST SCOTT STREET, PORT HUENEME CA, 93041. The biotechnology company can be reached via phone at 805-488-2800 or via email at [email protected] MarketBeat Community Rating for Stellar Biotechnologies (NASDAQ SBOT)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 203 (Vote Outperform)Underperform Votes: 206 (Vote Underperform)Total Votes: 409MarketBeat's community ratings are surveys of what our community members think about Stellar Biotechnologies and other stocks. Vote "Outperform" if you believe SBOT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBOT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/21/2019 by MarketBeat.com StaffFeatured Article: What is a good rate of return for a mutual fund?